Suppressor of TCR signaling 2 (Sts-2) as a potential immunotherapy target and prognostic biomarker in cervical cancer
The heightened expression of Sts-2 serves as a dual indicator of elevated T cell content and a favorable prognosis in cervical cancer.
Authors
- Xiaoqing Guo (ORCID: https://orcid.org/0000-0002-2493-5156)
- Yinlong Chen
- Qingliang Zheng (ORCID: https://orcid.org/0000-0002-5626-8423)
- Qin Chen (ORCID: https://orcid.org/0000-0003-3417-3092)
Institutions
- Sun Yat-sen University (CN)
- Shanghai First Maternity and Infant Hospital (CN)
- Eighth Affiliated Hospital of Sun Yat-sen University
Publication Details
- Journal
- Journal of Gynecologic Oncology
- Published
- 2025-09-16
- DOI
- https://doi.org/10.3802/jgo.2026.37.e20
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province